Lv1
20 积分 2026-04-28 加入
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
2小时前
待确认
Use of machine learning approach to predict depression in the elderly in China: A longitudinal study
3个月前
已完结
Deep learning habitat radiomics based on ultrasound for predicting preoperative locally progression and postoperative recurrence risk of thyroid cancer: a multicenter study
3个月前
已完结
Reducing burnout among nurses: The role of high-involvement work practices and colleague support
4个月前
已完结
皖公网安备34019202002308
